Experimental hookworm vaccine shows promising protection in phase 2 human trial
Hookworm infects an estimated 113 million people globally primarily in sub-Saharan Africa, Southeast Asia and South America. It is a major cause of iron-deficiency anemia in children and pregnant women.
Read More